glycidyl nitrate has been researched along with Granulomatous Disease, Chronic in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balfour Sartor, R; Bleich, A; Hedrich, HJ; Hopf, S; Li, F; Mähler, M; van Lith, HA | 1 |
Aiko, S; Conner, EM; Fuseler, JA; Grisham, MB | 1 |
Adam, AA; Colman, RW; Janardham, R; Kettner, CA; Majluf-Cruz, A; Sartor, RB; Stadnicki, A | 1 |
Anderle, SK; Geratz, JD; Lombardy, RJ; Pryzwansky, KB; Schwab, JH; Tidwell, RR | 1 |
Anderle, SK; Geratz, JD; Pryzwansky, KB; Schwab, JH; Tidwell, RR | 1 |
5 other study(ies) available for glycidyl nitrate and Granulomatous Disease, Chronic
Article | Year |
---|---|
Genetic dissection of granulomatous enterocolitis and arthritis in the intramural peptidoglycan-polysaccharide-treated rat model of IBD.
Topics: Animals; Arthritis; Disease Models, Animal; Enterocolitis; Female; Genetic Linkage; Genetic Predisposition to Disease; Granulomatous Disease, Chronic; Inflammatory Bowel Diseases; Peptidoglycan; Quantitative Trait Loci; Rats; Rats, Inbred F344; Rats, Inbred Lew | 2009 |
Effects of cyclosporine or FK506 in chronic colitis.
Topics: Animals; Blood Pressure; Body Weight; Colitis; Colon; Cyclosporine; Female; Granulomatous Disease, Chronic; Intestinal Mucosa; Liver; Nitrates; Nitrites; Organ Size; Peptidoglycan; Polysaccharides; Rats; Rats, Inbred Lew; Spleen; Tacrolimus | 1997 |
Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats.
Topics: Acute-Phase Proteins; Animals; Arthritis; Boron Compounds; Disease Models, Animal; Disease Susceptibility; Enzyme Inhibitors; Factor XI; Female; Granulomatous Disease, Chronic; Humans; Inflammation; Intestinal Diseases; Kallikreins; Kininogens; Oligopeptides; Peptidoglycan; Prekallikrein; Rats; Rats, Inbred Lew | 1998 |
Streptococcal cell wall-induced systemic disease. Beneficial effects of trans-bis(5-amidino-2-benzimidazolyl)ethene, a novel, macrophage-directed anti-inflammatory agent.
Topics: Animals; Benzimidazoles; Cell Membrane; Female; Granulomatous Disease, Chronic; Inflammation; Liver; Macrophages; Microscopy, Electron; Peptidoglycan; Polysaccharides; Rats; Rats, Inbred Lew; Spleen; Streptococcus; Structure-Activity Relationship | 1991 |
Suppression of streptococcal cell wall-induced arthritis by a potent protease inhibitor, bis(5-amidino-2-benzimidazolyl)methane.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Benzimidazoles; Cell Wall; Chemical and Drug Induced Liver Injury; Female; Granulomatous Disease, Chronic; Inflammation; Joints; Peptidoglycan; Rats; Rats, Inbred Lew; Spleen; Streptococcus pyogenes | 1988 |